Leader Of Synthetic Drugs Distribution Ring Sentenced To 10 Years In Prison
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Leader Of Synthetic Drugs Distribution Ring Sentenced To 10 Years In Prison

Leader Of Synthetic Drugs Distribution Ring Sentenced To 10 Years In Prison

June 22, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Rosa Valle-Lopez
Phone Number: (571) 387-5045

SANTA ANA, Calif. - A Newport Beach man who orchestrated a wide-reaching conspiracy that smuggled, manufactured and distributed millions of dollars worth of analogue drugs which were used to manufacture synthetic cannabinoids has been sentenced to 120 months in federal prison. 

Sean Libbert, 41, was sentenced late last night by United States District Judge Cormac J. Carney.  Libbert organized and led a drug trafficking conspiracy that manufactured, marketed and sold synthetic cannabinoids - commonly called “spice” - under the brand name of “Da Kine Blend.”  When he pleaded guilty last year, Libbert admitted that at least 100 kilograms of “spice” was manufactured using the analogue chemicals he provided, and that he knew the “spice” was being distributed for human consumption.  He pleaded guilty last November to four felony offenses: conspiring to manufacture, possess and distribute controlled substance analogues; conspiracy to smuggle controlled substance analogues into the United States; being a felon in possession of firearms and ammunition; and money laundering.

“Spice” is known as an analogue drug because its chemical composition is very similar to a controlled substance.  Analogues are intended to have a substantially similar or greater physiological effect than the narcotics they mimic. Popular with teenagers and younger adults because of the cheaper cost and glossy packaging, “spice” has been linked to overdoses, serious injuries and deaths across the country.  In fact, the 2014 indictment - which was the first in the Central District of California involving drug analogues - alleged that chemicals distributed by Libbert nearly killed a victim in Florida who had ingested them. Though containing (the active ingredient in marijuana) and despite it being commonly referred to as “fake marijuana,” “spice” is considered by scientists and health officials to be much more dangerous than marijuana because of its high potency, and because the quality and quantity of chemicals used to make the “spice” is unregulated.  The chemical analogues are typically manufactured in clandestine laboratories in China.
          
Over the course of 16 months in 2011 and 2012, Libbert’s organization smuggled over 200 pounds of chemicals into the U.S., knowing that the drugs would be used to manufacture “spice” that was smoked or taken orally.  During yesterday’s lengthy sentencing hearing, Judge Carney noted that Libbert used fraudulent documents and misbranded labels to smuggle the chemical analogues from China.
   
As part of the scheme, Libbert incorporated a series of companies, opened up a series of bank accounts and private mailboxes, and sold more than $5 million worth of “spice” to people across the United States, including other distributors and individual users.
           
Previously in this case, two other defendants pleaded guilty, including a Chinese national who sold Libbert and his associates synthetic drugs that were smuggled into the United States.  Another three defendants charged in separate cases pleaded guilty to conspiring with Libbert to manufacture, possess and distribute controlled substance analogues.  These other five defendants are expected to be sentenced by Judge Carney later this year.
           
The investigation into the analogue drug ring was conducted by the Los Angeles (High-Intensity Drug Trafficking Area) Southern California Drug Task Force, which operates under the auspices of the Drug Enforcement Administration.   The Task Force includes special agents with U.S. Immigration and Customs Enforcement’s Homeland Security (HSI), the Drug Enforcement Administration and IRS Criminal Investigation.

In July 2012, HIDTA investigators executed a series of federal search warrants and seized several luxury vehicles, hundreds of pounds of analogues, and firearms -including a rifle, a shotgun, two pistols, and approximately 700 rounds of ammunition, all of which Libbert was prohibited from possessing as a result of three prior felony convictions, including a 2002 drug trafficking conviction.

In addition to the drug and firearms charges, Libbert also pleaded guilty to one count of money laundering stemming from his purchase of real estate in Ohio using drug proceeds. Investigators seized more than $1.1 million in assets connected to the case - including more than $700,000 in profits from the sale of Libbert’s former residence in San Juan Capistrano - all of which have been administratively forfeited to the United States.

This case is being prosecuted by Assistant United States Attorney Carol Alexis Chen of the Organized Crime Drug Enforcement Task Force.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Brian M. Clark Special Agent in Charge - Los Angeles
@dealosangeles
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster